Alizadeh Shaabanali, Mahmoudi Ghafar Ali, Solhi Hassan, Sadeghi-Sedeh Bahman, Behzadi Reza, Kazemifar Amir Mohammad
Assistant Professor, General Surgeon, Department of Surgery, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Assistant Professor, Legal Medicine and Clinical Toxicologist, Department of Internal Medicine, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Addict Health. 2015 Winter-Spring;7(1-2):60-5.
Acute and chronic pain is prevalent in patients with opioid dependence. Lack of knowledge concerning the complex relationship between pain, opioid use, and withdrawal syndrome can account for the barriers encountered for pain management. This study was designed to evaluate the efficacy of sublingual (SL) buprenorphine for post-operative analgesia, compared with intravenous (IV) morphine.
A total of 68 patients, aged 20-60 years were randomly selected from whom had been underwent laparotomy due to acute abdomen in a University Teaching Hospital in Arak, Iran, and were also opioid (opium or heroin) abuser according to their history. After end of the surgery and patients' arousal, the patients were evaluated for abdominal pain and withdrawal syndrome by visual analog scale (VAS) and clinical opioid withdrawal score (COWS), respectively 1, 6, and 24 h after the surgery. They received either morphine 5 mg IV or buprenorphine 2 mg SL, 1 h after end of the surgery, and then every 6 h for 24 h.
VAS was 4.47 ± 0.73 and 2.67 ± 0.53 at h 6 and 24 in buprenorphine group, respectively. The corresponding score was 5.88 ± 0.69 and 4.59 ± 0.74 in morphine group. At the same time, patients in buprenorphine experienced less severe withdrawal syndrome.
The present study confirmed the efficacy of SL buprenorphine as a non-invasive, but effective method for management of post-operative pain in opioid dependent patients. Result of this study showed that physicians can rely on SL buprenorphine for post-operative analgesia.
急性和慢性疼痛在阿片类药物依赖患者中普遍存在。缺乏对疼痛、阿片类药物使用和戒断综合征之间复杂关系的了解,可能是疼痛管理中遇到障碍的原因。本研究旨在评估舌下含服丁丙诺啡与静脉注射吗啡相比,用于术后镇痛的疗效。
从伊朗阿拉克一家大学教学医院中,随机选取68例年龄在20至60岁之间、因急腹症接受剖腹手术且有阿片类药物(鸦片或海洛因)滥用史的患者。手术结束且患者苏醒后,分别在术后1、6和24小时,通过视觉模拟评分法(VAS)和临床阿片类药物戒断评分(COWS)评估患者的腹痛和戒断综合征。术后1小时,他们接受5毫克静脉注射吗啡或2毫克舌下含服丁丙诺啡治疗,然后每6小时给药一次,持续24小时。
丁丙诺啡组在术后6小时和24小时的VAS评分分别为4.47±0.73和2.67±0.53。吗啡组相应的评分分别为5.88±0.69和4.59±0.74。同时,丁丙诺啡组患者的戒断综合征较轻。
本研究证实舌下含服丁丙诺啡是一种用于管理阿片类药物依赖患者术后疼痛的非侵入性但有效的方法。本研究结果表明,医生可以依靠舌下含服丁丙诺啡进行术后镇痛。